New insights into the pathogenesis of membranous nephropathy
- 1 March 2000
- journal article
- Published by Elsevier in Kidney International
- Vol. 57 (3) , 1204-1205
- https://doi.org/10.1046/j.1523-1755.2000.00950.x
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Complement-induced phospholipase A2 activation in experimental membranous nephropathy1 See Editorial by Shankland, p. 1204.Kidney International, 2000
- Complement (C5b-9) induces glomerular epithelial cell DNA synthesis but not proliferation in vitroKidney International, 1999
- Complement activates phospholipases and protein kinases in glomerular epithelial cellsKidney International, 1998
- Cyclin kinase inhibitors are increased during experimental membranous nephropathy: Potential role in limiting glomerular epithelial cell proliferation in vivoKidney International, 1997
- Effect of DP-1904, a thromboxane A2 synthase inhibitor, on passive Heymann nephritis in ratsEuropean Journal of Pharmacology, 1996
- Differential expression of transforming growth factor-β isoforms and receptors in experimental membranous nephropathyKidney International, 1996
- Characterization of a glomerular epithelial cell metalloproteinase as matrix metalloproteinase-9 with enhanced expression in a model of membranous nephropathy.Journal of Clinical Investigation, 1996
- Proteinuria in passive Heymann nephritis is associated with lipid peroxidation and formation of adducts on type IV collagen.Journal of Clinical Investigation, 1994
- Indomethacin reduces proteinuria in passive Heymann nephritis in ratsKidney International, 1987
- Experimental Membranous Glomerulonephritis in RatsJournal of Clinical Investigation, 1980